High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.

Authors:
Moritz J Strowitzki
Moritz J Strowitzki
Saarland University
Germany
Jana Scheer
Jana Scheer
University of Heidelberg
Alina S Ritter
Alina S Ritter
University of Heidelberg
Heidelberg | Germany
Claudia Volz
Claudia Volz
University of Heidelberg
Heidelberg | Germany

Br J Cancer 2019 Apr 27;120(7):675-688. Epub 2019 Feb 27.

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Background: Patients with borderline resectable colorectal liver metastases (CRLM) frequently receive neoadjuvant chemotherapy (NC) to reduce tumour burden, thus making surgical resection feasible. Even though NC can induce severe liver injury, most studies investigating tissue-based prognostic markers focus on tumour tissue. Here, we assessed the prognostic significance of pyruvate-dehydrogenase-kinase isoenzyme 4 (PDK4) within liver tissue of patients undergoing surgical resection due to CRLM.

Methods: Transcript levels of hypoxia-adaptive genes (such as PDK isoenzymes) were assessed in the tissue of healthy liver, corresponding CRLM, healthy colon mucosa and corresponding tumour. Uni- and multivariate analyses were performed. Responses to chemotherapy upon up- or down-regulation of PDK4 were studied in vitro.

Results: PDK4 expression within healthy liver tissue was associated with increased overall survival and liver function following surgical resection of CRLM. This association was enhanced in patients with NC. PDK4 expression in CRLM tissue did not correlate with overall survival. Up-regulation of PDK4 increased the resistance of hepatocytes and colon cancer cells against chemotherapy-induced toxicity, whereas knockdown of PDK4 enhanced chemotherapy-associated cell damage.

Conclusion: Our findings suggest that up-regulated PDK4 expression reduces hepatic chemotherapy-induced oxidative stress and is associated with improved postoperative liver function in patients undergoing multimodal treatment and resection of CRLM.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0406-9DOI Listing
April 2019
4 Reads

Publication Analysis

Top Keywords

pdk4 expression
12
surgical resection
12
healthy liver
8
liver
8
colorectal liver
8
liver function
8
liver metastases
8
multimodal treatment
8
pdk4
8
liver tissue
8
patients undergoing
8
resection crlm
8
crlm
5
tissue
5
survival liver
4
up- down-regulation
4
chemotherapy up-
4
responses chemotherapy
4
analyses performed
4
performed responses
4

References

(Supplied by CrossRef)
Article in CA Cancer J. Clin.
CE DeSantis et al.
CA Cancer J. Clin. 2014
Article in Ann. Surg. Oncol.
EK Abdalla et al.
Ann. Surg. Oncol. 2006
Article in J. Surg. Oncol.
MJ Strowitzki et al.
J. Surg. Oncol. 2017
Article in J. Clin. Oncol.
JN Vauthey et al.
J. Clin. Oncol. 2006
Article in Surgery
C Reissfelder et al.
Surgery 2014
Article in J. Hepatol.
SM Robinson et al.
J. Hepatol. 2013
Article in Ann. Surg. Oncol.
PJ Kneuertz et al.
Ann. Surg. Oncol. 2011
Article in Ann. Surg. Oncol.
SM Robinson et al.
Ann. Surg. Oncol. 2012
Article in Cancer Res.
S Kopetz et al.
Cancer Res. 2009
Article in Cell. Mol. Life Sci.
P Jordan et al.
Cell. Mol. Life Sci. 2000
Article in Int. Urol. Nephrol.
J Uozumi et al.
Int. Urol. Nephrol. 1993

Similar Publications